Entrada Therapeutics Inc (TRDA)

Dec 18, 2024

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com

Dec 18, 2024

Dec 17, 2024

(TRDA) Proactive Strategies - Stock Traders Daily

Dec 17, 2024

Dec 16, 2024

Recent Price Trend in Entrada Therapeutics (TRDA) is Your Friend, Here's Why - MSN

Dec 16, 2024

Dec 13, 2024

XTX Topco Ltd Takes $634,000 Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Dec 13, 2024

Dec 10, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Sold by Fmr LLC - MarketBeat

Dec 10, 2024

Dec 09, 2024

Is Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Recent Stock Performance Tethered To Its Strong Fundamentals? - Simply Wall St

Dec 09, 2024

Dec 08, 2024

Entrada Therapeutics (NASDAQ:TRDA) Upgraded at Roth Capital - Defense World

Dec 08, 2024

Dec 07, 2024

Roth Mkm Begins Coverage on Entrada Therapeutics (NASDAQ:TRDA) - MarketBeat

Dec 07, 2024

Dec 07, 2024

Roth MKM starts ‘overlooked’ Entrada Therapeutics with Buy rating - Yahoo Finance

Dec 07, 2024

Dec 07, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Janus Henderson Group PLC - MarketBeat

Dec 07, 2024

Dec 07, 2024

Jacobs Levy Equity Management Inc. Has $3.23 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Dec 07, 2024

Dec 03, 2024

Insider Sell Alert: Natarajan Sethuraman Sells Shares of Entrada Therapeutics Inc (TRDA) - GuruFocus.com

Dec 03, 2024

Dec 03, 2024

Entrada Therapeutics CFO sells shares worth nearly $120,000 By Investing.com - Investing.com Nigeria

Dec 03, 2024

Dec 03, 2024

Entrada Therapeutics president sells $320,619 in stock By Investing.com - Investing.com Nigeria

Dec 03, 2024

Dec 03, 2024

Entrada Therapeutics CFO sells shares worth nearly $120,000 - Investing.com India

Dec 03, 2024

Dec 03, 2024

Entrada Therapeutics president sells $320,619 in stock - Investing.com

Dec 03, 2024

Dec 03, 2024

Entrada Therapeutics stock hits 52-week high at $20.5 By Investing.com - Investing.com Canada

Dec 03, 2024

Nov 28, 2024

Massachusetts Financial Services Co. MA Invests $1.11 Million in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 28, 2024

Nov 26, 2024

Entrada Therapeutics (TRDA) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Nov 26, 2024

Nov 26, 2024

(TRDA) Investment Analysis and Advice - Stock Traders Daily

Nov 26, 2024

Nov 26, 2024

Connor Clark & Lunn Investment Management Ltd. Has $2.22 Million Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 26, 2024

Nov 17, 2024

Los Angeles Capital Management LLC Makes New $542,000 Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

500: Something went wrong - Investing.com UK

Nov 13, 2024

Nov 13, 2024

Entrada Therapeutics stock hits 52-week high at $20.28 By Investing.com - Investing.com Canada

Nov 13, 2024

Nov 11, 2024

Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 11, 2024

Nov 10, 2024

HC Wainwright Issues Positive Forecast for Entrada Therapeutics (NASDAQ:TRDA) Stock Price - Defense World

Nov 10, 2024

Nov 08, 2024

HC Wainwright Analysts Boost Earnings Estimates for TRDA - MarketBeat

Nov 08, 2024

Nov 08, 2024

Entrada Therapeutics (NASDAQ:TRDA) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

Nov 08, 2024

Nov 07, 2024

Entrada Therapeutics president sells shares worth $339,280 By Investing.com - Investing.com Australia

Nov 07, 2024

Nov 07, 2024

Equities Analysts Issue Forecasts for TRDA FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 07, 2024

HC Wainwright Has Positive Outlook of TRDA FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 06, 2024

Beyond The Numbers: 4 Analysts Discuss Entrada Therapeutics Stock - Benzinga

Nov 06, 2024

Nov 06, 2024

Oppenheimer Issues Positive Forecast for Entrada Therapeutics (NASDAQ:TRDA) Stock Price - MarketBeat

Nov 06, 2024

Nov 06, 2024

Entrada Therapeutics stock target increased on positive trial data By Investing.com - Investing.com UK

Nov 06, 2024

Nov 06, 2024

Entrada Therapeutics (NASDAQ:TRDA) Price Target Raised to $20.00 - MarketBeat

Nov 06, 2024

Nov 06, 2024

Entrada Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

Entrada Therapeutics’ Q3 2024 Financial Highlights - TipRanks

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics (NASDAQ:TRDA) Hits New 12-Month HighHere's What Happened - MarketBeat

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics stock hits 52-week high at $18.22 By Investing.com - Investing.com UK

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics : Corporate Presentation - Marketscreener.com

Nov 05, 2024

Nov 05, 2024

Entrada Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 05, 2024

Nov 02, 2024

Here's Why Momentum in Entrada Therapeutics (TRDA) Should Keep going - MSN

Nov 02, 2024

Oct 28, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Short Interest Down 19.1% in October - MarketBeat

Oct 28, 2024

Oct 28, 2024

Short Interest in Entrada Therapeutics, Inc. (NASDAQ:TRDA) Declines By 19.1% - Defense World

Oct 28, 2024

Oct 19, 2024

Here's What Could Help Entrada Therapeutics (TRDA) Maintain Its Recent Price Strength - MSN

Oct 19, 2024

Oct 19, 2024

Entrada Therapeutics president sells $10,800 in stock By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 18, 2024

Natarajan Sethuraman Sells 600 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock - MarketBeat

Oct 18, 2024